Alnylam Delivers 52% Product Revenue Growth in Q3, but Analysts Flag Slowing Amvuttra Momentum and Pipeline Delays

TTR franchise powers Alnylam’s Q3 results. Analysts cite decelerating Amvuttra growth and minor catalyst delays; Stifel cuts to Hold.